Carlos Penalillo Pimentel: Detection of Rare Blood Donor Phenotypes During Investigation of Serologic Discrepancies
Carlos Penalillo Pimentel, Affiliate member of the Peruvian Association for Quality in Health, shared a post on LinkedIn:
“Immunohematology
That is why this science is exciting and takes us to totally unexpected, unsuspected and statistically unthinkable destinations.
I arrive at my Service having scheduled to study some modification to the acid elution technique so that it is not so aggressive with red blood cells, we have 3 patients with autoimmune hemolytic anemia (AHAI) and we need to ensure that the units of blood we send them are as accurate as possible in compatibility and with identical phenotype.
One proposes and God disposes, I arrive and find on the work table a strong discrepancy of globular and serum group from the routine of the previous day, I focused on solving it while controlling the 3 autoanalyzer equipment that we manage. It was solved with the enzymatic method.
We also needed to perform phenotype extended to blood units, I selected from the previous day 12 R1R1 and 12 R2R2, from all of them, we are separating those special ones that serve us in cases of incompatibilities known as Anti M, Anti s, Anti Fy a, etc.
The usual thing is to find 2 or 3 negative Fy from the group of 24, today we had 5 and with great surprise two of them were Fy null, that is to say Fya – Fyb – (the ones in the photo)
In all these years that we have been looking for donors with an uncommon phenotype, we have only managed to genotype 2.
Something incredible, we will proceed to carry out molecular biology to enter them on the Peruvian list. These donors will one day save the life of a patient with that same uncommon phenotype, that is the supreme purpose of our work area, to provide solutions in a safe and timely manner.”
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy